Research Overview of CIALIPEX SIXPEX
CIALIPEX SIXPEX is a sildenafil citrate research compound manufactured by SIXPEX for in-vitro laboratory applications. Sildenafil citrate belongs to the phosphodiesterase type 5 (PDE5) inhibitor class, originally developed for cardiovascular research before finding widespread pharmaceutical applications. Researchers at Stroid UK Shop can examine this compound’s molecular mechanisms and physiological pathways in controlled laboratory environments. The formulation provides standardised concentrations for consistent experimental protocols across multiple research applications.
Laboratory Applications and Research Potential
Scientists investigate CIALIPEX SIXPEX in various research contexts including vascular biology studies, smooth muscle physiology, and nitric oxide signalling pathways. The compound’s PDE5 inhibition mechanism makes it valuable for examining cyclic guanosine monophosphate (cGMP) regulation in cellular models. Research teams studying cardiovascular function, pulmonary arterial pressure mechanisms, and endothelial cell responses utilise this compound in controlled experimental settings. Laboratories examining erection drugs and sildenafil citrate compounds benefit from standardised formulations for comparative analyses. Additional research applications include investigating smooth muscle relaxation pathways and examining the molecular basis of PDE5 enzyme interactions.
Technical Specifications and Storage
| Parameter | Value |
|---|---|
| Active Ingredient | Sildenafil Citrate |
| Manufacturer | SIXPEX |
| CAS Number | 171599-83-0 |
| Molecular Formula | C28H38N6O11S |
| Molecular Weight | 666.70 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Stability | Verify with supplier documentation |
Researchers should store CIALIPEX SIXPEX in appropriate laboratory conditions away from moisture and direct sunlight. The compound maintains stability under standard research facility storage protocols. Scientists working with SARMs research compounds and peptide investigations can integrate this PDE5 inhibitor into comprehensive molecular research programmes examining multiple signalling pathways.
Research Compliance and Safety
CIALIPEX SIXPEX is manufactured exclusively for in-vitro research applications and laboratory investigations. This product is not intended for human consumption, clinical use, or any therapeutic applications. Researchers must handle all compounds according to established laboratory safety protocols and institutional guidelines. All research activities should comply with relevant regulatory frameworks governing laboratory chemical use and experimental procedures.
